Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

A review proposes a link between two brain proteins and aging-related memory loss

A summary of earlier studies · Progress in neuro-psychopharmacology & biological psychiatry · Oct 15, 2026

What this means

This review looks at two brain proteins that help control inhibitory connections between nerve cells. It suggests they may work together in brain aging, but this idea is not yet proven.

Plain-English summary written by an AI model from the abstract. The original is below.

Tested inSummary of earlier studies
Who it was tested in
A narrative review of earlier studies, no new experiments
Kind of research
A summary of earlier studies

The science

Original title
The potential role of the gephyrin-CNTNAP4 interface in brain aging: Mechanisms of inhibitory circuit dysfunction and cognitive decline.
Authors
Baothman A, Faheem SA, Al-Kuraishy HM et al.
Journal
Progress in neuro-psychopharmacology & biological psychiatry
Published
Oct 15, 2026
Study type
Review

Abstract

Brain aging is a multifactorial process characterized by progressive deterioration of synaptic integrity, impaired neuronal connectivity, and cognitive decline. Physiological brain aging involves a natural decline in cognitive function due to reduced synaptic connections, and synaptic integrity. However, the brain maintains plasticity, allowing individuals to adapt through lifelong learning and targeted lifestyle interventions. Conversely, pathological brain aging refers to abnormal, accelerated neurological decline that extends far beyond typical age-related changes, characterized by noteworthy brain atrophy, and is a primary driver of neurodegenerative diseases. Increasing evidence suggests that dysfunction of inhibitory neurotransmission represents a fundamental mechanism underlying age-associated alterations in brain circuitry. Among the molecular determinants governing inhibitory synaptic organization, the gephyrin, a principal postsynaptic scaffold protein, and contactin-associated protein-like 4 (CNTNAP4), a synaptic adhesion molecule involved in neuronal connectivity and neurotransmitter regulation, have independently emerged as important modulators of synaptic homeostasis. However, their potential functional interplay in normal and pathological brain aging remains poorly understood. Therefore, in this narrative review, we examine current knowledge regarding the structural and functional biology of gephyrin and CNTNAP4, emphasizing their contributions to inhibitory synapse maintenance, neuronal network stability, and age-related cognitive function. We further discuss convergent mechanisms through which disturbances in gephyrin-dependent receptor clustering and CNTNAP4-mediated synaptic adhesion may promote excitatory-inhibitory imbalance, synaptic destabilization, and circuit dysfunction during aging. Particular attention is given to shared downstream pathways implicated in brain senescence, including mechanistic target of rapamycin (mTOR) signaling, sirtuin-1 (SIRT1) activity, mitochondrial homeostasis, and neuronal autophagy. We propose the concept of a Gephyrin-CNTNAP4 interface as a previously underappreciated framework linking inhibitory synaptic scaffolding with cell-adhesion mechanisms in the aging brain. Understanding this interface may provide novel insights into the molecular basis of cognitive decline and facilitate the development of multi-target therapeutic strategies to preserve synaptic resilience and promote healthy brain aging.

Read it on PubMed ↗

Baothman A, Faheem SA, Al-Kuraishy HM et al. The potential role of the gephyrin-CNTNAP4 interface in brain aging: Mechanisms of inhibitory circuit dysfunction and cognitive decline. Progress in neuro-psychopharmacology & biological psychiatry. 2026. doi:10.1016/j.pnpbp.2026.111973. PMID: 42880581. https://pubmed.ncbi.nlm.nih.gov/42880581/

Related research

Study · Signal transduction and targeted therapy · Oct 28, 2026

Ginseng compound Rb1 eased signs of aging in the uterus in lab tests

Researchers found that Rb1 reduced aging signs in uterus lining cells and mouse uteruses. This does not show Rb1 helps aging uteruses in people.

Summary of earlier studiesReview · Current issues in molecular biology · Oct 27, 2026

Three common treatments and their possible links to aging and heart health

This review summarizes earlier studies on metformin, SGLT2 inhibitors, and fasting, and suggests a plan for using them together. It notes that key trials for fasting and for metformin in people without diabetes are missing.

Summary of earlier studiesReview · International journal of molecular sciences · Oct 27, 2026

How aging-like cell stress may affect the eye's surface

This review summarizes earlier studies on senescence, a state where cells stop dividing and release inflammatory signals. It suggests this state can help or harm the eye's surface, depending on the situation.

Summary of earlier studiesReview · Developmental biology · Oct 27, 2026

Hemocytes as nutrient-sensing regulators of immune function, lifespan, and intergenerational fitness in Drosophila melanogaster.

Hemocytes are the primary cellular components of the innate immune system in Drosophila melanogaster and share functional and molecular characteristics with vertebrate myeloid cells.

AnimalsLab or animal study · ACS chemical neuroscience · Oct 23, 2026

Pharmacological Activation of Autophagy Ameliorates Neuromuscular-Associated Defects and Extends Lifespan in a Caenorhabditis elegans Model of Spinal Muscular…

Spinal muscular atrophy (SMA) is a severe neuromuscular disorder caused by homozygous deletions or mutations in the SMN1 gene, resulting in reduced levels of the ubiquitously expressed survival motor neuron protein and…

Study · Cell death & disease · Oct 22, 2026

Apelin-13 protected brain cells from aging in cells and mice

Researchers found that apelin-13 helped brain cells resist aging signs by restoring their cleanup process. This work was done in cells and mice, so it does not show the same effect in people.

See all research on Rapamycin →

Report a problem